This activity is jointly provided by Global Education Group and Pacific Coast Reproductive Society.

Global Education Group

Pacific Coast Reproductive Society


Target Audience

Practicing physicians, physicians in training, and scientists in training in the field of reproductive medicine representing:

  • Andrology/Male Infertility
  • Reproductive Endocrinology
  • Obstetrics and Gynecology

Physician team members and allied health professionals representing:

  • Complementary Healthcare
  • Mental Health
  • Nursing
  • Reproductive Biologists/Laboratory Specialists
  • Outside Agencies
    • Third-Party Agencies
    • Genetic Laboratories
Statement of Need/Program Overview

The Pacific Coast Reproductive Society annual meeting is designed to provide Continuing Medical Education (CME) to physicians and allied healthcare professionals. The Pacific Coast Reproductive Society’s (PCRS) global commitment to exceptional patient care is embodied in the continuing medical education of physicians, their teams, and allied professionals. Promoting the highest standards of clinical practice, patient safety, and improved patient outcomes, related to the treatment of infertility, is consistent with the principles and goals of PCRS.

The Pacific Coast Reproductive Society’s CME program is based on the integration of clinical practice, scientific research, and education in Assisted Reproductive Technologies (ART) Consistent with these values, the following goals of PCRS/CME are intended to:

  1. Cultivate an atmosphere for thinking differently, unconventionally, or from new perspectives
  2. Offer thought-provoking programming enabling physicians, their teams, and allied health care professionals to provide superior medical care for patients
  3. Update or reinforce knowledge of current concepts, techniques, or practices
  4. Promote innovation in clinical practice and research
  5. Foster the integration of advances in relevant scientific and clinical research ensuring clinicians access to timely and relevant information
  6. Enable clinicians to recognize, practice, discuss, and apply new concepts, technologies, or practices, as they relate to the management of infertility in their specific area of clinical practice or research
  7. Further the identification and recognition of ethical, psychological, and cultural patient concerns
  8. Provide a forum for clinicians, academicians, and other professionals in allied fields to create or renew collegial and collaborative relationships that enhance their effectiveness, promote high standards of clinical practice, patient safety, and improved patient outcomes
  9. Facilitate a career-long continuum of medical education.
  10. PCRS accomplishes these goals through its Annual Meeting, which includes multiple disciplines (in reproductive medicine) in an educational program attracting regional, national, and international participants.
Educational Objectives

After completing this activity, the participant should be better able to:

  • Explain indications for testosterone therapy in men with infertility
  • Describe the stressors fertility patients experience during the normal course of treatment
  • Discuss the impact of COVID-19 on the mental health of fertility patients Identify the specific challenges that IVF collection poses for isolating and assessing the effectiveness of innovation in ART
  • Review friction points in the patient journey that make it difficult for patients to pursue or continue with treatment with the goal of reducing them
  • Review knowledge of basic principles of AI and machine learning
  • Identify losses and discover which factors of REI risk management result in the most impact to claims reduction


Dr. Andrea Braverman Clinical Professor with a joint appointment in the Department of Obstetrics and Gynecology and Psychiatry and Behavioral Medicine at Thomas Jefferson University
Dr. Eric Widra - Chief Medical Officer of SG Fertility
Dr. Joseph Conaghan - Board-Certified High-complexity Clinical Laboratory Director in the disciplines of Embryology and Andrology
Dr. Paul Lin - Physician at Seattle Reproductive Medicine and Medical Director of the Seattle Reproductive surgery center 
Dr. Paul Turek - Director of The Turek Clinic
Susan Crockin, JDSenior Scholar at Georgetown University Law Center’s O’Neill Institute for National & Global Health Law 
Dr. Zev Williams - Chief of the Division of Reproductive Endocrinology and Infertility at Columbia University Irving Medical Center
Kathe Wallace, PT - Independent study Clinical Instructor for the Division of Physical Therapy, Department of Rehabilitation Medicine, at the University of Washington in Seattle
Sean Tipton - Formulates and executes media and government affairs programs for ASRM,  the country’s leading organization for professionals involved in reproductive health care and infertility
Dr. Gloria Richard-Davis - Executive Director of the Division for Diversity, Equity and Inclusion Division (DDEI), a tenured Professor of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology (Ob/Gyn) at the University of Arkansas Medical Sciences (UAMS) 
Marcelle Cedars - Director of the UCSF Center for Reproductive Health and the Division of Reproductive Endocrinology and Infertility
Dr. Michael Eisenberg - editorial editor of Fertility and Sterility and associate editor of Andrology, on the editorial boards of the Journal of Assisted Reproduction and Genetics and the World Journal of Men’s Health
Dr. Serdar Bulun - John J. Sciarra Professor and Chair of the Department of Obstetrics and Gynecology at Northwestern University in Chicago
Dr. Barry Behr - Professor Emeritus of Obstetrics and Gynecology – Reproductive Endocrinology & Infertility at the Stanford University Medical Centre
Dr. Manuel Viotti - 3rd year REI fellow at University of California, San Francisco
Dr. David Albertini - Editor-in-Chief of the Journal of Assisted Reproduction and Genetics
Ms. Andria Besser - Board-certified genetic counselor and Director of Reproductive Genetics at the NYU Langone Fertility Center.
Dr. Alyssa Snider - Director of Clinical Genetic Services at Igenomix
Dr. Liesl Nel-Themaat - Associate Professor in the Stanford University School of Medicine
Dr. Abeer Salhia - Lab Director for Vios Fertility Institute Chicago and Milwaukee regions
Lauren Nevi, NP - Director of Advanced Practice Providers (APPs) for IVI RMA and family nurse practitioner at RMANJ
Hayley Rapp, NP - Women's Health Nurse Practitioner at Reproductive Medicine Associates of New Jersey and the Director of Clinical Education and Quality Assurance for IVI-RMA America
Tamara Tobias, NP - Women’s Health Care Nurse Practitioner & Manager, Seattle Reproductive Medicine (SRM)
Ciprian Paul Gheorghe - Maternal Fetal Medicine specialist and physician scientist
Maren Shapiro - 3rd year REI fellow at University of California, San Francisco 
Nina Vyas- 3rd year clinical fellow at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine at Weill Cornell Medical Center in New York
Grace Whiteley 3rd year REI fellow at the National Institutes of Health
Ijeoma Iko Reproductive Endocrinology and Infertility fellow at the University of Utah
Victoria Jiang- Board eligible OBGYN who is completing her second year in REI fellowship at Massachusetts General Hospital
Nirali Jain - 2nd year Reproductive Endocrinology fellow at NYU Fertility Center


Read More About the Faculty

Program Agenda

The registration desk is located in the lobby of the Esmeralda Ballroom.
Wednesday, March 22 10:00 AM - 6:30 PM
Thursday, March 23 7:00 AM - 4:30 PM
Friday, March 24 6:45 AM - 6:00 PM
Saturday, March 25 7:00 AM - 12:30 PM
Sunday, March 26 9:30 AM - 11:30 AM


View Full Schedule

Sessions with ABB Credit

All sessions are approved.


Approved by the American Board of Bioanalysis (ABB) for up to 18 hours. 

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].

Instructions for Obtaining Credit

In order to receive credit for this activity, the participant must attend the conference and complete a program evaluation. Certificates of credit will be emailed to learners 3-4 weeks after the conclusion of the conference.

  • At the conclusion of the meeting, all eligible attendees will receive an email to complete the program evaluation.
  • PCRS provides the post-test to attendees three weeks after the conclusion of the event to evaluate the retention of the knowledge gained by attending the sessions. Attendees must complete the post-test to earn CME.

System Requirement

- 1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
512 MB of RAM (1 GB recommended)

- Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome

- For HTML Client – Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)

- 1.83 GHz Intel Core Duo or faster processor
512 MB of RAM (1 GB recommended)
MAC OS X 10.12, 10.13 and 10.14

- Mozilla Firefox, Apple Safari, Google Chrome

- For HTML Client – Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)


Fee Information& Refund/Cancellation Policy

There is a fee for this educational activity.

Disclosures of Relevant Financial Relationships

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

David Albertini

Nothing to Disclose

Barry Behr

Employee: intilabs; Fellow                                                 Stock Options Holder: TMRW; Thread Robotics; Orchid Health; AIVF

Andria Besser

Nothing to Disclose

Andrea Braverman

Nothing to Disclose

Marcelle Cedars

Nothing to Disclose

Joseph Conaghan

Consulting Fee: Irvine Scientific                                                                  Speakers' Bureau: Irvine Scientific

Susan Crockin

Nothing to Disclose

Serdar Ekrem Bulun

Consulting Fee: Parexel Biotech

Michael Eisenberg

Consulting Fee: Ro, Sandstone, Hannah, Underdog, Doveras, VSeat

Ciprian Gheorghe

Nothing to Disclose

Ijeoma Iko

Nothing to Disclose

Victoria Jiang

Nothing to Disclose

Paul Lin

Nothing to Disclose

Liesl Nel-Themaat

Nothing to Disclose

Lauren Nervi

Consulting Fee: Ferring Pharmaceuticals

Hayley Rapp

Nothing to Disclose

Gloria Richard-Davis

Consulting Fee: Astella Pharmaceutical, Ferring Pharmaceutical                       Speaker's Bureau: Astella Pharmaceutical, Millicient Pharmaceutical

Abeer Salhia

Nothing to Disclose

Maren Shapiro

Nothing to Disclose

Alyssa C Snider

Employee: Igenomix Inc

Sean Tipton

Nothing to Disclose

Tamara Tobias

Consulting Fee: Ferring Pharmaceuticals                                                 Honoraria: Ferring Pharmaceuticals

Paul Turek

Owner: CellArts, Inc
Mandalmed, Inc                                                                      Consulting Fee: Progyny, Inc
DxNow, Inc; BioQ, Inc; Doximity, Inc; Future Family, Inc; Inherent Biosciences, Inc; Arex Bioscience, Inc                                                                                        Stockholder: Doximity Inc;
Cell Arts Inc; BioQ Inc;
Mandalmed, Inc (biologics)                                                                          Stock Options Holder: Inherent Bioscience, Inc; Arex Bioscience Inc;; Future Family Inc

Manuel Viotti

Nothing to Disclose

Nina Vyas

Nothing to Disclose

Katherine Wallace

Nothing to Disclose

Grace Whiteley

Nothing to Disclose

Eric A Widra

Nothing to Disclose

Zev Williams

Nothing to Disclose


The planners and managers at Global Education Group have no relevant financial relationships to disclose.

The planners and managers at Pacific Coast Reproductive Society have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Pacific Coast Reproductive Society do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.